37,000 bottles labeled as one drug might be filled with pills of another medication

David J. Neal
·1 min read

Pills of one arthritis pain medication might have wound up in 37,200 bottles with the label for another arthritis pain medication of much greater strength, according to an FDA enforcement alert.

Glenmark Pharmaceuticals is recalling four lots of 100-count 25 mg Indomethacin bottles because they might be labeled as being 100-count bottles of 250 mg Naproxen. At those strengths, Indomethacin comes in capsules while Naproxen comes as orange, uncoated tablets.

The label for 100-count bottles of 25 mg strength Indomethacin capsules.
The label for 100-count bottles of 25 mg strength Indomethacin capsules.

READ MORE: Drug treating depression, anxiety, PTSD, OCD recalled after ingredient tests poorly

The label for 100-count bottles of 250 mg Naproxen tablets.
The label for 100-count bottles of 250 mg Naproxen tablets.

Through Indomethacin and Naproxen both treat pain and inflammation, Drugs.com’s comparison says “the risk of stomach-related and cardiovascular side effects may be higher with Indomethacin than that seen with other NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) such as ibuprofen.”

Recalled lot numbers are 19231903, expiration 4/2025; 19231858, expiration 4/2025; 19231881, expiration 4/2025; 19233484, expiration 8/2025; and 19233490, expiration 8/2025.

If you have one of the recalled bottles, return them to your pharmacy. If you have any medical issues from taking the wrong drug, see a medical professional.